Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860932 · ClinicalTrials.gov registry record · NA
A Palliative Care Model Impact on Knowledge and Attitudes
A NA study of Multiple Sclerosis, MS, sponsored by Hunter College of City University of New York.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT06860932: Recruiting NA study of Multiple Sclerosis, MS, sponsored by Hunter College of City University of New York.
NCT06860932 is a NA study of Multiple Sclerosis, MS that is actively recruiting participants, run by Hunter College of City University of New York. The registered enrollment target is 50 participants, below the 60-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (17% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06860932, a NA study of Multiple Sclerosis, MS, is actively recruiting participants, sponsored by Hunter College of City University of New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is using a central, computer-generated simple randomization technique. Participants will be randomly assigned to groups within the constraints of ensuring balanced representation of gender, ethnicity, and race. One-half of the patients are randomized to the decision aid video model, and one-half will serve as controls and receive a palliative care (PC) informational sheet. Sessions are designed to be consistent with PC principles of care using constructs from the Murray's transition theory including knowledge development coupled with advanced care planning (ACP)-to drive palliative care alongside curative treatment, and to support people with chronic progressive illnesses. The 2 groups will complete the demographic forms, and pre- and post-tests, at baseline and after three months. The intervention group will view the video decision aid, which takes 10 minutes, during their follow up appointment. The controls will read written information of the same content shown on the video and will complete similar questionnaires. The video opens with empathic statements regarding the situation in which patients may find themselves, including an introduction about medical decisions, and statements regarding values and spiritual beliefs and their impact on decision-making. The video translates the information into actionable medical orders using a three-goal framework: life-prolonging care, limited/blended care, and comfort care. The video describes the features of each of the goals of care and the risks and benefits of each option using visual images that illustrate the interventions. Patients will review the video using iPads and will be able to review the video again as needed. The Flesch-Kincaid ease score for the video narration is 71.6; for the "Conversation" piece, it is 65.9. These indicate that the passages require approximately a 7th or 8th grade reading level, which Flesch suggests makes them "easy to read" and "plain English," respectively. The goal of th
Primary Outcome
The patient treatment preferences (i.e., care considerations, discontinuation of care, versus continued full care) for neurological care. The preferences will be measured based on a questionnaire asking patients about their preferences after viewing the PC video or reading the written material.
Conditions Studied
Interventions
- BEHAVIORAL Palliative care video comprises the conversation and advance directives.
- BEHAVIORAL Palliative care written material
Study Locations (2)
New York
- Judith Jaffe Multiple Sclerosis Center - New York
- Hunter College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06860932 shows while recruiting
NCT06860932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 60-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Multiple Sclerosis, MS appearing as the primary indexed condition, and to 2 interventions - of which Palliative care video comprises the conversation and advance directives. is the first listed.
NCT06860932 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06860932 about?
NCT06860932 is a clinical study titled "A Palliative Care Model Impact on Knowledge and Attitudes". This study is using a central, computer-generated simple randomization technique. Participants will be randomly assigned to groups within the constraints of ensuring balanced representation of gender, ethnicity, and race. One-half of the patients are randomized to the decision aid video model, and ...
What is the current status of trial NCT06860932?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-02-01. Estimated completion is 2026-06-30.
What conditions does trial NCT06860932 study?
This clinical trial studies the following conditions: Multiple Sclerosis, MS.
What interventions are being tested in trial NCT06860932?
The interventions under investigation include: Palliative care video comprises the conversation and advance directives. (BEHAVIORAL), Palliative care written material (BEHAVIORAL).
Who is sponsoring clinical trial NCT06860932?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860932 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis, MS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
COMPLETED · NA
-
Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis
COMPLETED · NA
-
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING · Phase 1
-
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
RECRUITING · Phase 1
-
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI